Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc. on June 6, 2025, reporting events occurring on June 2, 2025. The Company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol VTAK.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and does not contain financial performance data.
Material Changes
On June 2, 2025, the Company discontinued the employment of Marie-Claude Jacques, who served as Chief Commercial Officer. Mr. David Jenkins, the Executive Chairman of the Board and Chief Executive Officer, has assumed the role of Chief Commercial Officer on an interim basis until a permanent replacement is engaged.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors related to this personnel change. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the official announcement regarding the departure of the Chief Commercial Officer.
- Monitor future filings for the appointment of a permanent Chief Commercial Officer.
- Review the Company's most recent 10-K or 10-Q for current financial performance metrics, as this 8-K does not include them.